Kadil, Adel N.

HRN: 21-68-75  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2022
CEFUROXIME 750MG (VIAL)
07/16/2022
07/22/2022
IV
450mg
Q8Hrs
Sepsis
Waiting Final Action 
07/18/2022
CEFTRIAXONE 1G (VIAL)
07/18/2022
07/24/2022
IVT
675mg
Q12
T/C Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: